Related Experiment Videos
Lecithinized ascorbic acid (PC-AS) effectively inhibits murine pulmonary metastasis
M Takenaga1, R Igarashi, T Nakayama
1Division of Drug Delivery Systems, Institute of Medical Science, St. Marianna University School of Medicine, Kawasaki, Japan.
Anticancer Research
|June 16, 1999
Summary
Lecithinized ascorbic acid (PC-AS) enhances lipophilicity and shows improved efficacy over ascorbic acid (ASA). PC-AS demonstrates superior in vivo anti-metastatic activity, particularly in pulmonary metastasis models.
Area of Science:
- Biochemistry
- Pharmacology
- Oncology
Background:
- Ascorbic acid (ASA) is a vital nutrient with therapeutic potential but limited lipophilicity and efficacy.
- Developing derivatives of ASA can enhance its pharmacokinetic properties and therapeutic applications.
- Understanding the impact of modifications on ASA's biological activity is crucial for drug development.
Purpose of the Study:
- To synthesize and evaluate the pharmacological activity of lecithinized ascorbic acid (PC-AS), a novel derivative of ASA.
- To compare the antioxidative, cytotoxic, and anti-metastatic effects of PC-AS with unmodified ASA.
- To investigate the biodistribution and in vivo efficacy of PC-AS in a murine metastasis model.
Main Methods:
- Synthesis of PC-AS by covalently binding lecithin to ASA.
- In vitro evaluation of antioxidative activity using superoxide anion scavenging assays.
- In vitro assessment of cytotoxicity against Meth A-T cells under normal and serum-free conditions.
- In vivo biodistribution studies and a murine pulmonary metastasis model using Meth A-T cells.
- Assessment of colony formation and pulmonary invasion in treated mice.
Main Results:
- PC-AS exhibited significant antioxidative activity, approximately 60% of ASA's potency.
- PC-AS demonstrated in vitro cytotoxicity against Meth A-T cells, with enhanced potency under serum-free conditions.
- Biodistribution studies showed PC-AS had a longer circulation time in blood compared to ASA.
- Intravenous administration of PC-AS significantly reduced pulmonary metastasis colony formation in vivo, outperforming ASA.
- PC-AS reduced the accumulation of tumor cells in the lungs, indicating an anti-metastatic effect.
Conclusions:
- Lecithinization enhances the lipophilicity and in vivo anti-metastatic efficacy of ascorbic acid.
- PC-AS shows promising potential as an anti-cancer agent, particularly for preventing lung metastasis.
- The improved efficacy of PC-AS may be attributed to altered biodistribution, antioxidative properties, and cytotoxicity.